A novel synthetic iminoquinone, BA-TPQ, as an anti-breast cancer agent: in vitro and in vivo activity and mechanisms of action

By Wang Wei  

Breast Cancer Research and Treatment, Vol. 123, Iss. 2, 2010-09 ,pp. : 321-331

Springer Publishing Company

Access to resources Recommend Favorite

Anti-metastatic efficacy and safety of MMI-166, a selective matrix metalloproteinase inhibitor

By Maekawa Ryuji   Maki Hideo   Wada Tohru   Yoshida Hiroshi   Nishida-Nishimoto Kazuyo   Okamoto Hiroyuki   Matsumoto Yayoi   Tsuzuki Hiroshige   Yoshioka Takayuki  

Clinical and Experimental Metastasis, Vol. 18, Iss. 1, 2000-01 ,pp. : 61-66

Springer Publishing Company

Access to resources Recommend Favorite

Ilex kudingcha C.J. Tseng (Kudingcha) has in vitro anticancer activities in MCF-7 human breast adenocarcinoma cells and exerts anti-metastatic effects in vivo

By        

Oncology Letters, Vol. 5, Iss. 5, 2013-01 ,pp. : 1744-1748

Spandidos Publications

Access to resources Recommend Favorite

Novel cis-restricted β-lactam combretastatin A-4 analogues display anti-vascular and anti-metastatic properties in vitro

By                

Oncology Reports, Vol. 29, Iss. 2, 2013-01 ,pp. : 585-594

Spandidos Publications

Access to resources Recommend Favorite

Augmented anti-metastatic efficacy of a selective matrix metalloproteinase inhibitor, MMI-166, in combination with CPT-11

By Maki Hideo   Hojo Kanji   Tanaka Hidekazu   Sawada Takuko   Maekawa Ryuji   Yoshioka Takayuki  

Clinical and Experimental Metastasis, Vol. 19, Iss. 6, 2002-10 ,pp. : 519-526

Springer Publishing Company

Access to resources Recommend Favorite